CC BY-NC-ND 4.0 · Organic Materials 2022; 4(03): 61-72
DOI: 10.1055/a-1896-6890
Supramolecular Chemistry
Original Article

Selective Recognition of Ammonium over Potassium Ion with Acyclic Receptor Molecules Bearing 3,4,5-Trialkylpyrazolyl Groups

Felix Fuhrmann
a   Institut für Organische Chemie, Technische Universität Bergakademie Freiberg, Leipziger Strasse 29, 09599 Freiberg, Germany
,
Wilhelm Seichter
a   Institut für Organische Chemie, Technische Universität Bergakademie Freiberg, Leipziger Strasse 29, 09599 Freiberg, Germany
,
a   Institut für Organische Chemie, Technische Universität Bergakademie Freiberg, Leipziger Strasse 29, 09599 Freiberg, Germany
› Author Affiliations
 


Abstract

Among the 1,3,5-trisubstituted 2,4,6-triethylbenzenes bearing pyrazolyl groups, the compounds with 3,5-dimethylpyrazolyl moieties were found to be effective receptors for ammonium ions (NH4 +). The current study investigated the extent to which the incorporation of an additional alkyl group in the 4-position of the pyrazole ring affects the binding properties of the new compounds. 1H NMR spectroscopic titrations and investigations using isothermal titration calorimetry revealed that this small structural variation leads to a significant increase in the binding strength towards NH4 + and also improves the binding preference for NH4 + over K+. In addition to the studies in solution, crystalline complexes of the new triethyl- and trimethylbenzene derivatives, bearing 3,4,5-trialkylpyrazolyl groups, with NH4 +PF6 were obtained and analyzed in detail. It is noteworthy that two of the crystal structures discussed in this work are characterized by the presence of two types of ammonium complexes. Studies focusing on the development of new artificial ammonium receptors are motivated, among other things, by the need for more selective ammonium sensors than those based on the natural ionophore nonactin.


#

Introduction

The development of new organic molecules suitable for the construction of effective sensor systems, which can selectively recognize ammonium ions (NH4 +) over other ions, is of great research interest. Selective detection of NH4 + is needed to answer various environmental[1a] – [f] and medical[2a] – [f] questions, but due to the similarity of ammonium and potassium ions, the realization of this goal represents a challenge. For example, the ionic radii of the ammonium ion (r = 1.40 Å, coordination number, CN = 4)[3a] and the potassium ion (r = 1.38 Å, CN = 6)[3b] differ only slightly.

Most of the sensors used today are based on the natural ionophore nonactin ([Figure 1a]); however, its binding preference for NH4 + over K+ is not as pronounced as necessary,[4a] [b] so alternatives are being sought.[5a]

Zoom Image
Figure 1 Structure of the natural ionophore nonactin (a) and examples of tripodal benzene derivatives bearing pyrazolyl groups (b).

In the development of artificial receptors, both macrocyclic[5a] – [g] and acyclic compounds[4a],[6],[7a] – [j],[8a] [b] were considered. Among the acyclic compounds, tripodal[7a] – [e] and hexapodal[8a] [b] benzene derivatives with pyrazolyl or indazolyl groups, for example, were examined ([Figure 1b]). The ability of these compounds to act as ammonium receptors was investigated both in solution and in the crystalline state[7a] – [e],[8a] (for examples of crystalline ammonium complexes, see [Figure 2]).

Zoom Image
Figure 2 Schematic representations of noncovalent interactions in the crystal structures of two exemplary complexes of hexapodal and tripodal benzene derivatives with NH4PF6: complexes of hexakis[(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)methyl]benzene (left)[8a] and of 1,3,5-tris[(4-methyl-1H-indazol-1-yl)methyl]-2,4,6-triethylbenzene (right).[9]

Studies with pyrazole-containing molecules yielded promising results and showed that the substitution pattern of the pyrazole ring has a significant influence on the binding properties of the tested compounds. 1,3,5-Trisubstituted 2,4,6-triethylbenzenes bearing 3,5-dimethylpyrazolyl groups proved to be particularly promising receptors for NH4 +.[7a] – [d] The improved NH4 +/K+ selectivity of these compounds compared to analogues with unsubstituted pyrazolyl moieties was mainly attributed to the presence of the three pyrazole 3-CH3 substituents,[7b] which prevent the formation of 2 : 1 receptor–substrate complexes with K+ and thereby the coordination of this cation. By replacing the methyl groups in positions 3 and 5 of the pyrazole ring with phenyl groups, a significant decrease in the binding affinity was observed.[7e] Given the interesting properties of the tripodal benzene derivatives bearing 3,5-dimethylpyrazolyl groups, the current studies investigated the extent to which the incorporation of an additional alkyl group in the 4-position of the pyrazole ring affects the binding properties of the triethyl- and trimethylbenzene derivatives 14 towards NH4 + ([Figure 3]).

Zoom Image
Figure 3 Structures of the new 1,3,5-trisubstituted 2,4,6-triethylbenzene or 2,4,6-trimethylbenzene derivatives bearing 4-alkyl-3,5-dimethylpyrazolyl groups.

1H NMR spectroscopic titrations and investigations by isothermal titration calorimetry (ITC) revealed a significant increase in the binding affinity of compounds 14, bearing 3,4,5-trimethyl or 4-ethyl-3,5-dimethylpyrazolyl groups, compared to the analogues containing 3,5-dimethylpyrazolyl moieties. Particularly noteworthy is the excellent NH4 +/K+ binding preference of the tested compounds. Crystal structures of the ammonium complexes formed by compounds 14 provide valuable information about the interactions that are responsible for the stabilization of the crystalline complexes.


#

Results and Discussion

Synthesis of compounds 1 – 4 and their analogues 5 and 6

Compounds 14 were prepared through the reaction of 1,3,5-tris(bromomethyl)-2,4,6-triethylbenzene (7) or 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene (8) with the corresponding pyrazole derivative, such as 3,4,5-trimethyl-1H-pyrazole (9) and 4-ethyl-3,5-dimethyl-1H-pyrazole (10), as shown in Scheme [1]. In addition to the target compounds 14, derivatives 5 and 6 (Scheme [1]) have been synthesized in order to compare the binding properties of the new compounds containing 3,4,5-trialkylpyrazolyl groups with those of the known compounds bearing 3,5-dimethylpyrazolyl moieties.

Zoom Image
Scheme 1 Reaction conditions for the synthesis of compounds 16: NaH, CH3CN, N2 atmosphere (63% of 1, 65% of 2, 72% of 3, 76% of 4, 87% of 5, 63% of 6). Reaction conditions for the preparation of 9 and 10: 3-methylpentan-2,4-dione or 3-ethylpentan-2,4-dione, hydrazine monohydrate, CH3OH, 0 °C and then reflux (90% of 9, 78% of 10).

All reactions were carried out under a nitrogen atmosphere, at room temperature, in dry acetonitrile, and in the presence of sodium hydride as a base. The progress of the reactions was monitored by thin layer chromatography (see Experimental Section).

The pyrazoles 9 and 10 were prepared by the reaction of 3-methylpentan-2,4-dione or 3-ethylpentan-2,4-dione with hydrazine monohydrate in methanol (see Scheme [1]). The by-product 3,5-dimethyl-1H-pyrazole (11), which could not be completely removed by distillation, for example, was successfully separated by taking advantage of the relatively small differences in the NH acidity between pyrazole derivatives 911. In this procedure, a dichloromethane solution of the crude reaction product was treated with a NaOH solution (2 – 5%), resulting in the removal of 11.

The pyrazole 11 used for the synthesis of compounds 5 and 6 was purchased commercially.


#

Binding studies: 1H NMR spectroscopic titrations and microcalorimetric titrations

The ability of the compounds 14 to act as ammonium receptors was evaluated on the basis of 1H NMR titrations and ITC.

The 1H NMR titrations of 14 with ammonium hexafluorophosphate (NH4PF6) and potassium hexafluorophosphate (KPF6) were performed in CD3CN or a CD3CN/CDCl3 mixture at a constant concentration of the receptor. Examples of the complexation-induced shifts observed for compounds 14 during the titration with NH4PF6 and KPF6 are given in [Figures 4] and [5] as well as in the Supporting Information (Figures S2 – S7 and Tables S1 – S2).

Zoom Image
Figure 4 Partial 1H NMR spectra (500 MHz, CD3CN/CDCl3 2 : 1, v/v, 298 K) of compound 3 after the addition of (a) 0.00 – 2.05 equiv of NH4PF6 ([3] = 2.53 mM) and (b) 0.00 – 20.09 equiv of KPF6 ([3] = 2.50 mM). Shown are the chemical shifts of the CH3 A (marked by diamonds), CH3 C (marked by triangles), CH3 D and CH3 E signals of 3, for labeling, see (c).
Zoom Image
Figure 5 Partial 1H NMR spectra (500 MHz, CD3CN, 298 K) of compound 1 after the addition of (a) 0.00 – 2.02 equiv of NH4PF6 ([1] = 2.51 mM). Shown are the chemical shifts of the CH3 A (marked by diamonds), CH3 D,F,G, CH2 B (marked by triangles) and CH2 C signals of 1, for labeling, see (b).

This type of compounds can interact with NH4 + via three charge-enhanced NH⋯N hydrogen bonds involving the nitrogen atom N2 of each of the three pyrazole units. In all cases, the complexation-induced shift of the pyrazole 5-CH3 signal indicates that the heterocyclic ring undergoes a rotation during the complexation process to ensure binding of the NH4 + by the nitrogen atom N2 (see also 2D NMR experiments, Figures S26 and S27 in the Supporting Information).

The titration data were evaluated on the basis of WinEQNMR[10] and SupraFit[11] programs, and the complex stoichiometry was analyzed by using the mole ratio method.[12] The NMR experiments in CD3CN/CDCl3 (2 : 1, v/v) revealed that compounds 14 form very strong 1 : 1 complexes with the ammonium ion under the chosen experimental conditions (K 11 > 105 · M−1). In contrast, only a weak binding of the potassium ion could be detected (K 11 ~ 102 · M−1).

1H NMR titrations of compounds 1 and 2 with NH4PF6 were also performed in CD3CN and showed very strong binding as well, but weaker than in the solvent mixture, as expected. Due to the very strong binding of the ammonium ion, the NMR method could not be used for the exact determination of the binding constants, but this was realised by using the ITC method. The determined association constants are summarized in [Table 1].

Table 1 Association constantsa,b for the complexation of ammonium hexafluorophosphate (NH4PF6 ) and potassium hexafluorophosphate (KPF6 ) with compounds 16 (for further details, see [Table 2])

Compound

Trialkylbenzene/substituents in the pyrazole ring

K 11 c [M−1]

ITCd

K 11 c [M−1]

NMRe

aAverage K 11 values from multiple titrations: 1H NMR spectroscopic titrations [CD3CN/CDCl3 (2 : 1, v/v) or CD3CN, 298 K; evaluated on the basis of WinEQNMR[10] and SupraFit[11] programs or microcalorimetric titrations [CH3CN/CHCl3 (2 : 1, v/v) or CH3CN, 298 K; evaluated on the basis of NanoAnalyze and SupraFit programs]. bErrors were estimated at < 10%. c1 : 1 Receptor–substrate binding model. dDetermined by using ITC; the binding constants were too large to be accurately determined by the NMR method. eDetermined by the NMR method. fNot determined.

Acetonitrile/chloroform 2 : 1 (v/v)

NH4PF6

KPF6

1

Triethylbenzene/3,4,5-trimethyl

1 280 000

119

2

Triethylbenzene/4-ethyl-3,5-dimethyl

1 150 000

89

5

Triethylbenzene/3,5-dimethyl

451 000

135

3

Trimethylbenzene/3,4,5-trimethyl

752 000

117

4

Trimethylbenzene/4-ethyl-3,5-dimethyl

678 000

105

6

Trimethylbenzene/3,5-dimethyl

326 000

123

Acetonitrile

1

Triethylbenzene/3,4,5-trimethyl

221 000c

f

2

Triethylbenzene/4-ethyl-3,5-dimethyl

152 000c

f

The microcalorimetric titrations were carried out by adding increasing amounts of the ammonium hexafluorophosphate to a solution of the corresponding receptor in a mixture of dry CH3CN/CHCl3 (compounds 16) or in CH3CN (compounds 1 and 2). An example is given in [Figure 6] and further examples can be found in the Supporting Information (Figures S11 – S17). The binding constants were determined from three independent microcalorimetric titrations and in all cases the best fit of the titration data was obtained with the 1 : 1 receptor–ammonium binding model (data were evaluated on the basis of NanoAnalyze and SupraFit programs; see [Table 2]).

Zoom Image
Figure 6 ITC thermogram (left) and titration curve-fitting (right) for the titration of 1 with NH4PF6 in dry CH3CN/CHCl3 2 : 1 (v/v) (the heat of dilution has been subtracted). Titration mode: addition of NH4PF6 (c syringe = 5.9 mM) into 1 (c cell = 0.5 mM) at 298 K in 46 steps, calorimeter: MicroCal VP-ITC.

Table 2 Results of microcalorimetric titrations of compounds 1 – 6 with ammonium hexafluorophosphatea – c

Compound

lg K 11

(K 11 [M−1])

ΔG

[kJ/mol]

ΔH

[kJ/mol]

TΔS

[kJ/mol]

ΔS

[J/mol K]

aIn dry CH3CN/CHCl3 2 : 1 (v/v) at 25 °C. Used concentrations: [receptor] = 0.5 mM, [NH4PF6] = 5.9 mM (calorimeter: MicroCal VP-ITC); [receptor] = 2.5 mM, [NH4PF6] = 18.2 mM (calorimeter: Thermal Activity Monitor 2277). bIn dry CH3CN at 25 °C. cThe errors listed are the standard deviations for a minimum of three replicated ITC titrations.

Acetonitrile/chloroform 2 : 1 (v/v)a

1

6.11 ± 0.01

(1 280 000 ± 7700)

−34.86 ± 0.01

−30.3 ± 0.2

4.6 ± 0.2

15.5 ± 0.5

2

6.06 ± 0.01

(1 150 000 ± 1900)

−34.59 ± 0.01

−28.0 ± 0.4

6.6 ± 0.4

22.3 ± 1.2

5

5.65 ± 0.01

(451 000 ± 10 000)

−32.28 ± 0.06

−28.6 ± 0.2

3.7 ± 0.3

12.4 ± 0.9

3

5.88 ± 0.01

(752 000 ± 5900)

−33.54 ± 0.02

−33.0 ± 0.2

0.6 ± 0.2

1.9 ± 0.7

4

5.83 ± 0.03

(678 000 ± 48 000)

−33.28 ± 0.18

−31.7 ± 0.5

1.6 ± 0.4

5.3 ± 1.2

6

5.51 ± 0.02

(326 000 ± 11 000)

−31.47 ± 0.08

−32.5 ± 0.5

−1.0 ± 0.4

−3.5 ± 1.5

Acetonitrileb

1

5.34 ± 0.03

(221 000 ± 17 300)

−30.50 ± 0.19

−26.4 ± 0.1

4.1 ± 0.1

13.9 ± 0.4

2

5.18 ± 0.02

(152 000 ± 8700)

−29.58 ± 0.14

−24.6 ± 0.4

5.0 ± 0.4

16.6 ± 1.4

The results of the binding studies showed a significant influence of the additional alkyl group at the 4-position of the pyrazole ring on the binding strength of the tested compounds 14. In comparison to the analogues bearing 3,5-dimethylpyrazolyl groups, a two- to almost three-fold increase in binding affinity could be observed under the chosen experimental conditions. Although both the presence of an additional methyl substituent and the presence of an ethyl substituent increase the receptor efficiency, the former leads to a somewhat stronger increase in binding strength for electronic[13a] and steric[13b] [c] reasons. According to the molecular modelling calculations of the free receptors, the pyrazole 4-ethyl groups cause a stronger shielding of the receptor cavity than the 4-methyl substituents, which may also affect the binding process of the substrate.

In agreement with previous studies,[7a] [b] [e] the strong solvent effects were also observed for the new representatives of this class of compounds. The use of acetonitrile instead of an acetonitrile/chloroform mixture (2 : 1, v/v) resulted in a six- to seven-fold decrease in the binding strength of the tested receptor molecules towards ammonium hexafluorophosphate.

Triethylbenzene-based compounds are more effective receptors for the ammonium ion than their trimethylbenzene-based analogues, as shown by comparing the binding properties of compounds 1, 2, and 5 with those of 3, 4, and 6, respectively (see [Tables 1] and [2] and [Figure 7]). Among the tested compounds, compound 1 was identified as the most powerful ammonium receptor.

Zoom Image
Figure 7 Schematic illustration of how the binding efficiency of the investigated compounds is affected by the substituent at 4-position of the pyrazole ring (considered is the binding strength to ammonium hexafluorophosphate). The higher affinity of the triethylbenzene derivatives in comparison to their trimethylbenzene-based analogues is also schematically illustrated in this figure.

Consideration of the results of the binding experiments revealed that the incorporation of an additional alkyl group into the 3,5-dimethylpyrazole unit resulted in a gain in binding free energy of about 2 kJ/mol.

It is particularly noteworthy that all compounds exhibit excellent binding preference for the ammonium ion compared to the potassium ion. Compounds consisting of triethylbenzene scaffold and 3,4,5-trialkylpyrazole units (compounds 1 and 2) were found to have the best ability to discriminate between the two ions.

As mentioned above, the complexation of the ammonium ion occurs mainly by NH⋯N hydrogen bonds (as shown by previous and current binding studies). This is also indicated by molecular modelling calculations ([Figure 8]) and confirmed by the results of crystallographic studies (see below).

Zoom Image
Figure 8 Energy-minimized structure of the 1 : 1 complex 2•NH4PF6 (two different views; the ammonium ion is located in the cavity of compound 2). MacroModel V.11.0, OPLS_2001 force field, MCMM, 50 000 steps; color code: H, white; C, grey; N, blue.

#

Crystal structures of the receptor molecules 1 and 3 and of the ammonium complexes 1a–4a

In the course of our experimental work we succeeded to grow crystalline ammonium complexes of compounds 14. They comprise the complexes 1•NH4 +PF6 (1 : 1) (1a), 2•NH4 +PF6 (2 : 2) (2a), 3•NH4 +PF6 •HOC2H4OH (1 : 1 : 0.5) (3a), and 4•NH4 +PF6 •C2H5OH (2 : 2 : 2) (4a) (see [Figure 9]). Moreover, crystallization of the receptors 1 and 3 yielded guest-free crystal structures. The crystals of the complexes were obtained by slow evaporation of the solvent from an ethanol or ethane-1,2-diol solution of a 1 : 5 mixture of the respective compound and NH4 +PF6 , whereas the crystals of 1 and 3 were obtained from hexane and methanol, respectively. Crystallographic data, experimental parameters and selected details of the refinement calculations are summarized in Table S3. The conformation of the receptor (host) molecule can be described by a set of dihedral angles formed by their aromatic building blocks. Their values together with selected torsion angles are listed in Table S4, while information regarding intermolecular interactions in the crystals is summarized in Table S5.

Zoom Image
Figure 9 Structures of compounds 1 – 4 and the composition of the molecular crystals of the complexes 1a4a.

The crystal structures of 1a4a are composed of the same kind of receptor–NH4 + units in which the NH4 + ion resides in a cavity created by the functionalized arms of the receptor molecule. The interaction of the cation with the receptor always involves the nitrogen atoms of the pyrazole units, designated as N(2), N(4) and N(6) in the figures showing the molecular structures.

Triethylbenzene-based compounds: Crystal structures of 1 and complexes 1a and 2a

Compound 1 crystallizes from hexane as colorless rods of the space group P-1 with two molecules in the unit cell. Two of the three 3,4,5-trimethylpyrazolyl moieties are directed to one side of the central benzene ring, while the third points in the opposite direction (aab arrangement). Taking the ethyl groups into account, the spatial arrangement of the substituents along the periphery of the benzene ring represents an abʼaaʼbb’ pattern (a = above, b = below, a’/b’ = ethyl; for details, see refs. 7c and 14),[7c],[14] as shown in [Figures 10a] and [11a]. The molecular conformation appears to be stabilized by two intramolecular C – H⋯π interactions[15] [d(H⋯Cg) 2.68, 2.77 Å] and one C – H⋯N bond[16] [d(H⋯N) 2.57 Å].

Zoom Image
Figure 10 Perspective views (ORTEP diagrams) of 1 (a) and the ammonium complex in the crystal structure 1a (b) including atom numbering and ring specification. The displacement ellipsoids are drawn at the 40% probability level. Dashed lines represent hydrogen bond interactions. In complex 1a, only the major disorder component of the PF6 ion is shown for clarity.
Zoom Image
Figure 11 Ball-and-stick representations (side views) of 1 (a) and complex 1a (b). Dashed lines represent hydrogen bond interactions.

For steric reasons, the presence of the ethyl groups on the central arene ring prevents the formation of molecular dimers (as observed for trimethylbenzene-based derivative, see below). In the present crystal structure, the C – H⋯N bonds created by the atoms N(2), N(4), and N(6), as well as C – H⋯π contacts, provide a three-dimensional supramolecular architecture. A packing representation of 1 is given in [Figure 12].

Zoom Image
Figure 12 Packing diagram of 1. Dashed lines represent hydrogen bond interactions.

Co-crystallization of receptor 1 and NH4 +PF6 from ethanol yields a complex of the structure displayed in [Figures 10b] and [11b], respectively. It should be noted here that the molecular structure of this complex is similar to those represented in published crystal structures of triethylbenzene-based receptors.[7a] – [d] The enhanced residual electron density near the PF6 ion indicates the presence of a O-H⋯F(P) bonded solvent molecule, which however could not be refined to an acceptable level. For this reason, a modified data set was generated using the SQUEEZE routine[17] of the PLATON program,[18] in which the contribution of the disordered molecule to the structural amplitudes was eliminated. A packing diagram of 1a viewed down the c-axis is depicted in [Figure 13].

Zoom Image
Figure 13 Packing diagram of 1a viewed down the crystallographic c-axis. Dashed lines represent hydrogen bond interactions. Nitrogen atoms are displayed as blue, oxygens as red, fluorine as green and phosphorous atoms as violet circles.

The crystal structure of 2a (space group P21/c) contains two independent but geometrically different complexes ([Figure 14a]). While the complex I adopts an aaʼaaʼab’ conformation, the substituents of the second complex follow an aaʼabʼab’ arrangement ([Figure 14b]). The ethyl groups flanked by pyrazole rings are held in their positions by intramolecular C – H⋯π interactions [d(H⋯Cg) 2.50 – 2.79 Å]. The conformational differences between the receptor molecules are also reflected by the dihedral angles between their pyrazole rings, which are 67.3(1)°, 11.7(2)° and 66.5(1)° for complex I and 75.7(1)°, 47.8(1)° and 29.0(1)° for complex II.

Zoom Image
Figure 14 (a) Perspective view (ORTEP diagrams) of the molecular structure 2a with atom labeling and specification of the aromatic rings. The displacement ellipsoids are drawn at the 40% probability level. (b) Ball-and-stick representations (side views) of the complexes in the crystal structure of 2a. Dashed lines represent hydrogen bond interactions.

Compared to 1a, the modification of the receptor molecule by introducing an ethyl group in 4-position of the pyrazole rings exerts a significant influence on the packing behaviour of the molecules in the crystal (see [Figure 15]). Only one C – H⋯F bond[19] and one C – H⋯π interaction of each complex contribute to the molecular association, so that essentially van der Waals forces contribute to the stabilization of the crystal structure.

Zoom Image
Figure 15 Packing diagram of 2a viewed down the crystallographic a-axis. Dashed lines represent hydrogen bond interactions.

#

Trimethylbenzene-based compounds: Crystal structures of 3 and complexes 3a and 4a

Crystal growing of the compound 3 from methanol yields colourless blocks of the space group P-1 with one molecule in the asymmetric unit of the cell. In the solid state, the three pyrazole rings adopt, in the same fashion as in 1, an aab arrangement (see [Figure 16]) with inclination angles of 79.9(1)°, 84.9(1)° and 86.0(1)° with respect to the plane of the benzene ring.

Zoom Image
Figure 16 Perspective view (ORTEP plot) of the molecular structure of 3 including atom numbering and ring specification (A – D). The displacement ellipsoids are drawn at the 40% probability level.

[Figure 17] shows that the crystal structure is composed of dimers of closely nested molecules held together by C – H⋯N [d(H⋯N) 2.49 – 2.65 Å] and C – H⋯π interactions [d(H⋯Cg) 2.67 Å].

Zoom Image
Figure 17 (a) Excerpt of the packing structure of 3. (b) Structure of the molecular dimer including the labelling of coordinating atoms. Dashed lines represent hydrogen bond interactions and dashed double lines C – H⋯π contacts.

The colourless plate-like crystals of 3a proved to be a solvate of the space group P-1 with the asymmetric part of the unit cell containing one complex unit 3•NH4 +PF6 and one half of ethane-1,2-diol, i.e. the latter molecule is located on a crystallographic symmetry center. The structure of the complex is shown in [Figure 18] In the crystal the receptor molecule exists in a symmetric conformation with an approximately coplanar arrangement (9.0°) of the pyrazole rings B and D. Within the receptor–NH4 + entity, N-H⋯N bond lengths are 2.03(5)–2.06(4) Å; the remaining hydrogen of NH4 + acts as a bifurcated binding site for formation of N-H⋯F bonds [d(H⋯F) 2.28(4), 2.51(4) Å] to the PF6 ion. The fluorine atoms F(3) and F(4) of this anion participate in the formation of O-H⋯F bonds [d(H⋯F) 2.45, 2.59 Å] to the solvent molecule.

Zoom Image
Figure 18 (a) Perspective view (ORTEP plot) of the molecular structure of complex 3a including atom numbering and ring specification (A – D). The displacement ellipsoids are drawn at the 40% probability level. (b) Ball-and-stick representation (side view) of complex 3a. Dashed lines represent hydrogen bond interactions.

The complexes are connected by C – H⋯F(P) type hydrogen bonds [d(H⋯F) 2.39 – 2.59 Å] and offset π⋯π interactions[20] [d(CgCg) 3.928(1) Å, slippage 0.710 Å], the latter involving the pyrazole rings B and D. A comparative view of the packing structure of 3a ([Figure 19]) and that of the ethyl-substituted analogous compound 1a reveals only minor differences, which is also evident from the similarity of cell parameters.

Zoom Image
Figure 19 Packing diagram of 3a viewed down the crystallographic c-axis. Dashed lines represent hydrogen bond interactions.

Crystal growth of compound 4 in the presence of NH4 +PF6 yields colourless prism-like crystals of the space group P-1 with two receptor molecules, two NH4 +PF6 and two molecules of two-fold disordered ethanol in the asymmetric unit of the cell (complex 4a). These components are connected to form two structurally similar complexes, as shown in [Figure 20]. Unlike 3a, in the present case, no direct interactions between the NH4 + ion and its counter ion are observed. Instead, in each of the complexes, one H atom of the cation is associated to the oxygen atom of the alcohol molecule. The OH hydrogen of each solvent molecule is connected to the PF6 ion [d(H⋯F) 2.16(5)–2.50(4) Å].

Zoom Image
Figure 20 Perspective view (ORTEP plot) of the molecular structure of 4a including atom numbering and ring specification (A – D). The displacement ellipsoids are drawn at the 30% probability level. For the sake of clarity, only one position of the disordered ethanol molecules is shown.

C – H⋯F type hydrogen bonds [d(H⋯F) 2.55 – 2.61 Å] connect the complexes to a three-dimensional supramolecular network. An excerpt of the packing structure of 4a is displayed in [Figure 21].

Zoom Image
Figure 21 Packing diagram of 4a. Dashed lines represent hydrogen bond interactions.

#
#
#

Conclusions

Representatives of the class of compounds consisting of a 1,3,5-trisubstituted 2,4,6-trialkylbenzene scaffold and bearing pyrazolyl groups are known to be able to act as ammonium receptors. The binding properties of these compounds towards NH4 + depend strongly on the substitution pattern of the pyrazole ring. In view of the promising properties of the derivatives bearing 3,5-dimethylpyrazolyl groups, the current studies investigated the extent to which the incorporation of an additional alkyl group in the 4-position of the pyrazole ring affects the binding properties of the new compounds 14.

Binding studies revealed a two- to three-fold higher binding affinity of compounds 14, bearing 3,4,5-trimethylpyrazolyl or 4-ethyl-3,5-dimethylpyrazolyl groups, compared to the analogues containing 3,5-dimethylpyrazolyl moieties. Particularly noteworthy is the improvement in the binding preference for NH4 + over K+, which is clearly visible when considering the binding strength of compounds 1, 2 and 5 towards these two ions (for example, K 11(NH4 +)/K 11(K+): 1 280 000 M−1/119 M−1 vs. 451 000 M−1/135 M−1 for 1 and 5, respectively). Compounds consisting of the triethylbenzene scaffold and 3,4,5-trialkylpyrazole units were identified as the strongest receptors and found to have the best ability to discriminate between the two ions under the chosen experimental conditions. As expected, the strong solvent effects shown in previous binding studies with this type of receptors were also observed for the new compounds.

Crystalline complexes of compounds 14 with NH4 +PF6 were characterized by X-ray diffraction studies (crystal structures 1a4a). In each case, the pyrazolyl units of the receptor are directed towards the same face of the central benzene ring (aaa arrangement of the functionalized side arms) and interact with the ammonium ion via three NH⋯N hydrogen bonds. The molecular structures of these complexes are similar to those of the previously reported crystal structures of triethylbenzene- and trimethylbenzene-based receptors.[7a] – [d] However, it is remarkable that two of the four crystal structures (2a and 4a) discussed in this work are characterized by the presence of two types of ammonium complexes. In the case of 2a, for example, the difference between the two 1 : 1 complexes is related to different conformations of the receptor molecules; the arrangement of substituents around the benzene ring follows an aaʼaaʼab’ (complex I) and an aaʼabʼab’ pattern (complex II). It is worth noting that the presence of two types of complexes was also observed by us for acyclic carbohydrate receptors in the crystal structures of complexes with glucopyranosides, which we have reported recently.[21] Among all crystalline complexes, direct contacts between NH4 + and PF6 (NH⋯F interactions) are observed for 1a3a, whereas solvent-mediated interactions between NH4 + and PF6 (NH⋯OH⋯F) are present in the ethanol-containing ammonium complex of the trimethylbenzene derivative 4. The supramolecular motifs observed in the crystal structures of the free receptors and the ammonium complexes give valuable insights into the phenomena of molecular recognition processes.


#

Experimental Section

Analytical TLC was carried out on silica gel 60 F254 plates employing hexane/ethyl acetate, toluene/ethyl acetate or chloroform/methanol mixtures as the mobile phase. Flash chromatography was carried out on silica gel (for details, see below). Melting points are uncorrected. Compounds 5 and 6 were prepared via reactions of 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene or 1,3,5-tris(bromomethyl)-2,4,6-triethylbenzene with 3,5-dimethyl-1H-pyrazole according to the procedure in refs. 7b, 22 and 23 (see also ref. 24).[7b],[22]–[24]

Procedures

General procedure for the synthesis of compounds 1 – 4

To 3,4,5-trimethyl- or 4-ethyl-3,5-dimethyl-1H-pyrazole (4.5 equiv) dissolved under a N2 atmosphere in anhydrous acetonitrile, sodium hydride (95%, 4.5 equiv) was added and the mixture was stirred for 30 minutes at room temperature. Then, 1,3,5-tris(bromomethyl)-2,4,6-triethylbenzene or 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene (1.0 equiv) was added and the reaction mixture was stirred at room temperature under a N2 atmosphere (the progress of the reactions was monitored by thin layer chromatography). The reaction was quenched with H2O (5 mL) and extracted with CHCl3 (3 × 10 mL). The organic layers were combined, dried over Na2SO4 and filtered, and the solvent was removed under reduced pressure. The residue was purified by flash chromatography using hexane/ethyl acetate, toluene/ethyl acetate or chloroform/methanol as the eluent. The crude products were recrystallized from methanol, ethanol or hexane.


#

1,3,5-Tris[(3,4,5-trimethyl-1H-pyrazol-1-yl)methyl]-2,4,6-triethylbenzene (1)

The reaction of 1,3,5-tris(bromomethyl)-2,4,6-triethylbenzene (250 mg, 0.57 mmol) with 3,4,5-trimethyl-1H-pyrazole (281 mg, 2.55 mmol) and NaH (95%, 64 mg, 2.55 mmol) in CH3CN (5 mL) afforded compound 1 as a white solid (flash chromatography: toluene/ethyl acetate, gradient 7 : 1 – 1 : 3, v/v; recrystallization from hexane).

Yield 190 mg (0.36 mmol, 63%).

R f = 0.56 (hexane/ethyl acetate 1 : 1 v/v).

M. p. 171 – 172 °C.

1H NMR (CDCl3, 500 MHz): δ = 5.19 (s, 6 H), 2.76 (q, J = 7.5 Hz, 6 H), 2.09 (s, 9 H), 2.00 (s, 9 H), 1.86 (s, 9 H), 0.86 (t, J = 7.5 Hz, 9 H) ppm.

13C NMR (CDCl3, 125 MHz): δ = 145.9, 145.0, 136.0, 130.8, 111.6, 47.5, 23.8, 14.8, 12.0, 9.9, 8.2 ppm.

MS (ESI): m/z calcd for C33H48 N6 + H+: 529.40 [M + H]+; found: 529.47.

Elemental analysis calcd (%) for C33H48 N6: C, 74.96%; H, 9.15%; N, 15.89%. Found: C, 74.96%; H, 9.04%; N, 16.07%.


#

1,3,5-Tris[(3,4,5-trimethyl-1H-pyrazol-1-yl)methyl]-2,4,6-trimethylbenzene (3)

The reaction of 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene (200 mg, 0.50 mmol) with 3,4,5-trimethyl-1H-pyrazole (249 mg, 2.26 mmol) and NaH (95%, 54 mg, 2.26 mmol) in CH3CN (5 mL) afforded compound 3 as a white solid (flash chromatography: chloroform/methanol, gradient 50 : 1 – 7 : 1, v/v; recrystallization from methanol).

Yield 176 mg (0.36 mmol, 72%).

R f = 0.72 (chloroform/methanol 16 : 1 v/v).

M. p. 246 – 247 °C.

1H NMR (CDCl3, 500 MHz): δ = 5.19 (s, 6 H), 2.23 (s, 9 H), 2.09 (s, 9 H), 1.98 (s, 9 H), 1.85 (s, 9 H) ppm.

13C NMR (CDCl3, 125 MHz): δ = 145.7, 138.1, 135.7, 131.4, 111.3, 48.7, 16.7, 12.0, 9.7, 8.1 ppm.

MS (ESI): m/z calcd for C30H42 N6 + H+: 487.36 [M + H]+; found: 487.39.

Elemental analysis calcd (%) for C30H42 N6: C, 74.03%; H, 8.70%; N, 17.27%. Found: C, 73.77%; H, 8.65%; N, 17.35%.


#

1,3,5-Tris[(4-ethyl-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-2,4,6-triethylbenzene (2)

The reaction of 1,3,5-tris(bromomethyl)-2,4,6-triethylbenzene (250 mg, 0.57 mmol) with 4-ethyl-3,5-dimethyl-1H-pyrazole (317 mg, 2.55 mmol) and NaH (95%, 64 mg, 2.55 mmol) in CH3CN (5 mL) afforded compound 2 as a white solid (flash chromatography: toluene/ethyl acetate, gradient 7 : 1 – 3 : 2, v/v, recrystallization from hexane).

Yield 210 mg (0.37 mmol, 65%).

R f = 0.65 (toluene/ethyl acetate 1 : 1 v/v).

M. p. 171 – 172 °C.

1H NMR (500 MHz, CDCl3): δ = 5.19 (s, 6 H), 2.78 (q, J = 7.5 Hz, 6 H), 2.30 (q, J = 7.5 Hz, 6 H), 2.11 (s, 9 H), 2.02 (s, 9 H), 1.00 (t, J = 7.5 Hz, 9 H), 0.80 (t, J = 7.5 Hz, 9 H) ppm.

13C NMR (125 MHz, CDCl3): δ = 145.3, 144.9, 135.5, 130.9, 118.5, 47.4, 23.9, 16.8, 15.6, 14.6, 12.0, 9.7 ppm.

MS (ESI): m/z calcd for C36H54 N6 + H+: 571.45 [M + H]+; found: 571.49.

Elemental analysis calcd (%) for C36H54 N6: C, 75.74%; H, 9.53%; N 14.72%. Found: C, 75.67%; H, 9.48%; N 14.86%.


#

1,3,5-Tris[(4-ethyl-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-2,4,6-trimethylbenzene (4)

The reaction of 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene (300 mg, 0.75 mmol) with 4-ethyl-3,5-dimethyl-1H-pyrazole (420 mg, 3.38 mmol) and NaH (95%, 85 mg, 3.38 mmol) in CH3CN (7 mL) afforded compound 4 as a white solid (flash chromatography: chloroform/methanol, gradient 99 : 1 – 13 : 1, v/v, recrystallization from ethanol).

Yield 303 mg (0.57 mmol, 76%).

R f = 0.63 (chloroform/methanol 16 : 1 v/v).

M. p. 213 – 214 °C.

1H NMR (500 MHz, CDCl3): δ = 5.19 (s, 6 H), 2.29 (q, J = 7.5 Hz, 6 H), 2.22 (s, 9 H), 2.11 (s, 9 H), 1.98 (s, 9 H), 1.00 (t, J = 7.5 Hz, 9 H) ppm.

13C NMR (125 MHz, CDCl3): δ = 145.2, 138.0, 135.4, 131.6, 118.2, 48.8, 16.8 (2C), 15.6, 12.0, 9.6 ppm.

MS (ESI): m/z calcd for C33H48 N6 + H+: 529.40 [M + H]+; found: 529.47.

Elemental analysis calcd (%) for C33H48 N6: C, 74.96%; H, 9.15%; N 15.89%. Found: C, 74.79%; H, 9.10%; N, 15.78%.

The pyrazoles 9 and 10 were prepared according to the procedures in refs. 25 and 26 (see also ref. 27).[25]–[27] In addition to the purification methods described there, a dichloromethane solution of the crude reaction product was treated with a NaOH solution (2 – 5%).

Crystallographic data. The intensity data were collected at 123 – 213 K on a IPDS-2T diffractometer (Stoe & Cie, 2002) with MoKα radiation (λ = 0.71 073 Å). Software for data collection and cell refinement: STOE X-AREA;[28] data reduction: X-RED.[28] Reflections were corrected for background, Lorentz and polarization effects. Preliminary structure models were derived by application of direct methods[29] and were refined by full-matrix least-squares calculation based on F 2 for all reflections.[30] With the exception of the disordered PF6 ion in 1a, all non-hydrogen atoms were refined anisotropically. Apart from the OH hydrogen atoms in 4a, all other H atoms were included in the models in calculated positions and were refined as constrained to bonding atoms. Crystallographic data for the structures in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication numbers CCDC 2 176 612 (1), CCDC 2 176 613 (1a), CCDC 2 176 616 (2a), CCDC 2 176 614 (3), CCDC 2 176 615 (3a) and CCDC 2 176 617 (4a). Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Read, Cambridge CB2 1EZ, UK (Fax: +44 -1223-336-033, Email: deposit@ccdc.cam.ac.uk).


#
#

Funding Information

F. F. thanks the Saxonian Ministry of Science, Culture and Tourism (SMWK) (project number 100 327 776) for his doctoral fellowship.

Open Access Funding by the Publication Fund of the Technische Universität Bergakademie Freiberg is gratefully acknowledged.


#
#
#

Conflict of Interest

The authors declare no conflict of interest.

  • References

    • 1a Ingildsen P, Olsson G. Water Sci. Technol. 2002; 46: 139
    • 1b Kaelin D, Rieger L, Eugster J, Rottermann K, Bänninger C, Siegrist H. Water Sci. Technol. 2008; 58: 629
    • 1c König A, Bachmann TT, Metzger JW, Schmid RD. Appl. Microbiol. Biotechnol. 1999; 51: 112
    • 1d Athavale R, Kokorite I, Dinkel C, Bakker E, Wehrli B, Crespo GA, Brand A. Anal. Chem. 2015; 87: 11990
    • 1e Reichert J, Sellien W, Ache HJ. Freseniusʼ J. Anal. Chem. 1991; 339: 467
    • 1f Winkler S, Rieger L, Saracevic E, Pressl A, Gruber G. Water Sci. Technol. 2004; 50: 105
    • 2a Zhang W, Zhang J. PCT Int. Appl. WO2016/040048 A1, 2016
    • 2b Radomska A, Bodenszac E, Głab S, Koncki R. Talanta 2004; 64: 603
    • 2c Magalhães JMCS, Machado AASC. Analyst 2002; 127: 1069
    • 2d Wolfbeis OS, Li H. Biosens. Bioelectron. 1993; 8: 161
    • 2e Kovács B, Nagy G, Dombi R, Tóth K. Bionsens. Bioelectron. 2003; 18: 111
    • 2f Kawabata Y, Sugamoto H, Imasaka T. Anal. Chim. Acta 1993; 283: 689
    • 4a Siswanta D, Hisamoto H, Tohma H, Yamamoto N, Suzuki K. Chem. Lett. 1994; 23: 945
    • 4b Bühlmann P, Pretsch E, Bakker E. Chem. Rev. 1998; 98: 1593
    • 5a Suzuki K, Siswanta D, Otsuka T, Amano T, Ikeda T, Hisamoto H, Yoshihara R, Ohba S. Anal. Chem. 2000; 72: 2200
    • 5b Sasaki S, Amano T, Monma G, Otsuka T, Iwasawa N, Citterio D, Hisamoto H, Suzuki K. Anal. Chem. 2002; 74: 4845
    • 5c Graf E, Kintzinger JP, Lehn JM, LeMoigne J. J. Am. Chem. Soc. 1982; 104: 1672
    • 5d Kim H-S, Park HJ, Oh HJ, Koh YK, Choi J-H, Lee D-H, Cha GS, Nam H. Anal. Chem. 2000; 72: 4683
    • 5e Rahman MA, Kwon N-H, Won M-S, Hyun M-H, Shim Y-B. Anal. Chem. 2004; 76: 3660
    • 5f Jon SY, Kim J, Kim M, Park SH, Jeon WS, Heo J, Kim K. Angew. Chem. Int. Ed. 2001; 40: 2116
    • 5g Campayo L, Pardo M, Cotillas A, Jaúregui O, Yunta MJ, Cano C, Gomez-Contreras F, Navarro P, Sanz AM. Tetrahedron 2004; 60: 979
  • 6 Pazik A, Skwierawska A. Sens. Actuators, B 2014; 196: 370
    • 7a Chin J, Walsdorff C, Stranix B, Oh J, Chung HJ, Park S-M, Kim K. Angew. Chem. Int. Ed. 1999; 38: 2756
    • 7b Chin J, Oh J, Jon SY, Park SH, Walsdorff C, Stranix B, Ghoussoub A, Lee SJ, Chung HJ, Park S-M, Kim K. J. Am. Chem. Soc. 2002; 124: 5374
    • 7c Koch N, Seichter W, Mazik M. CrystEngComm 2017; 19: 3817
    • 7d Schulze MM, Koch N, Seichter W, Mazik M. Eur. J. Org. Chem. 2018; 2018: 4317
    • 7e Jonah TM, Mathivathanan L, Morozov AN, Mebel AM, Raptis RG, Kavallieratos K. New J. Chem. 2017; 41: 14835
    • 7f Rueda-Zubiaurre A, Herrero-García N, del Rosario Torres M, Fernández I, Osío Barcina J. Chem. Eur. J. 2012; 18: 16884
    • 7g Ahn KH, Kim S-G, Jung J, Kim K-H, Kim J, Chin J, Kim K. Chem. Lett. 2000; 29: 170
    • 7h Kim H-S, Kim D-H, Kim KS, Choi J-H, Choi H-J, Kim S-H, Shim JH, Cha GS, Nam H. Talanta 2007; 71: 1986
    • 7i Kim H-S, Kim D-H, Kim KS, Choi H-J, Shim JH, Jeong IS, Cha GS, Nam H. J. Inclusion Phenom. Macrocyclic Chem. 2003; 46: 201
    • 7j Oh KS, Lee C-W, Choi HS, Lee SJ, Kim KS. Org. Lett. 2000; 2: 2679
    • 8a Koch N, Seichter W, Mazik M. Tetrahedron 2015; 71: 8965
    • 8b Arunachalam M, Ahamed BN, Ghosh P. Org. Lett. 2010; 12: 2742
  • 9 Fuhrmann F, Meier E, Seichter W, Mazik M. Acta Cryst. 2022; E78 DOI: 10.1107/S2056989022006867.
  • 10 Hynes MJ. J. Chem. Soc., Dalton Trans. 1993; 311
  • 11 Hübler C. Chem. – Methods 2022; e202200006 preprint DOI: 10.1002/cmtd.202200006.
  • 14 Schulze M, Schwarzer A, Mazik M. CrystEngComm 2017; 19: 4003
    • 15a Nishio M. Phys. Chem. Chem. Phys. 2011; 13: 13873
    • 15b Nishio M, Umezawa Y, Honda K, Tsuboyama S, Suezawa H. CrystEngComm 2009; 11: 1757
    • 15c Nishio M, Umezawa Y, Suezawa H, Tsuboyama S. The Importance of Pi-Interactions in Crystal Engineering: Frontiers in Crystal Engineering. Tiekink ERT, Zukerman-Schpector J. Hoboken: Wiley; 2012: 1
  • 16 Desiraju GR, Steiner T. The Weak Hydrogen Bond in Structural Chemistry and Biology. Oxford University Press; Oxford: 1999
  • 17 Spek AL. Acta Cryst. 2015; C71: 9
  • 18 Spek AL. Acta Cryst. 2009; D65: 148
  • 19 Grepioni F, Cojazzi G, Draper SM, Scully N, Braga D. Organometallics 1998; 17: 296
    • 20a Dance I. Encyclopedia of Supramolecular Chemistry. Atwood JL, Steed JM. New York: Dekker; 2004: 1076
    • 20b James SL. Encyclopedia of Supramolecular Chemistry. Atwood JL, Steed JM. New York: Dekker; 2004: 1093
    • 20c Salonen LM, Ellermann M, Diederich F. Angew. Chem. Int. Ed. 2011; 50: 4808
    • Angew. Chem. 2011; 123: 4908
    • 21a Köhler L, Seichter W, Mazik M. Eur. J. Org. Chem. 2020; 2020: 7023
    • 21b Köhler L, Hübler C, Seichter W, Mazik M. RSC Adv. 2021; 11: 22221
  • 22 Koch N, Mazik M. Synthesis 2013; 45: 3341
  • 23 Andree SNL, Sinha AS, Aakeröy CB. Molecules 2018; 23: 163
  • 24 Hartshorn CM, Steel PJ. Aust. J. Chem. 1995; 48: 1587
  • 25 Morin TJ, Wanniarachchi S, Gwengo C, Makura V, Tatlock HM, Lindeman SV, Bennett B, Long GJ, Grandjean F, Gardinier JR. Dalton Trans. 2011; 40: 8024
  • 26 Hillier AC, Zhang XW, Maunder GH, Liu SY, Eberspacher TA, Metz MV, McDonald R, Domingos A, Marques N, Day VW, Sella A, Takats J. Inorg. Chem. 2001; 40: 5106
  • 27 Ardizzoia GA, Brenna S, Durini S, Therrien B, Trentin I. Dalton Trans. 2013; 42: 12265
  • 28 Stoe & Cie. X-AREA and X-RED. Darmstadt, Germany: STOE & Cie GmbH; 2009
  • 29 Sheldrick GM. Acta Cryst. 2015; A71: 3
  • 30 Sheldrick GM. Acta Cryst. 2015; C71: 3

Correspondence


Publication History

Received: 08 June 2022

Accepted after revision: 06 July 2022

Accepted Manuscript online:
11 July 2022

Article published online:
11 August 2022

© 2022. The authors. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

  • References

    • 1a Ingildsen P, Olsson G. Water Sci. Technol. 2002; 46: 139
    • 1b Kaelin D, Rieger L, Eugster J, Rottermann K, Bänninger C, Siegrist H. Water Sci. Technol. 2008; 58: 629
    • 1c König A, Bachmann TT, Metzger JW, Schmid RD. Appl. Microbiol. Biotechnol. 1999; 51: 112
    • 1d Athavale R, Kokorite I, Dinkel C, Bakker E, Wehrli B, Crespo GA, Brand A. Anal. Chem. 2015; 87: 11990
    • 1e Reichert J, Sellien W, Ache HJ. Freseniusʼ J. Anal. Chem. 1991; 339: 467
    • 1f Winkler S, Rieger L, Saracevic E, Pressl A, Gruber G. Water Sci. Technol. 2004; 50: 105
    • 2a Zhang W, Zhang J. PCT Int. Appl. WO2016/040048 A1, 2016
    • 2b Radomska A, Bodenszac E, Głab S, Koncki R. Talanta 2004; 64: 603
    • 2c Magalhães JMCS, Machado AASC. Analyst 2002; 127: 1069
    • 2d Wolfbeis OS, Li H. Biosens. Bioelectron. 1993; 8: 161
    • 2e Kovács B, Nagy G, Dombi R, Tóth K. Bionsens. Bioelectron. 2003; 18: 111
    • 2f Kawabata Y, Sugamoto H, Imasaka T. Anal. Chim. Acta 1993; 283: 689
    • 4a Siswanta D, Hisamoto H, Tohma H, Yamamoto N, Suzuki K. Chem. Lett. 1994; 23: 945
    • 4b Bühlmann P, Pretsch E, Bakker E. Chem. Rev. 1998; 98: 1593
    • 5a Suzuki K, Siswanta D, Otsuka T, Amano T, Ikeda T, Hisamoto H, Yoshihara R, Ohba S. Anal. Chem. 2000; 72: 2200
    • 5b Sasaki S, Amano T, Monma G, Otsuka T, Iwasawa N, Citterio D, Hisamoto H, Suzuki K. Anal. Chem. 2002; 74: 4845
    • 5c Graf E, Kintzinger JP, Lehn JM, LeMoigne J. J. Am. Chem. Soc. 1982; 104: 1672
    • 5d Kim H-S, Park HJ, Oh HJ, Koh YK, Choi J-H, Lee D-H, Cha GS, Nam H. Anal. Chem. 2000; 72: 4683
    • 5e Rahman MA, Kwon N-H, Won M-S, Hyun M-H, Shim Y-B. Anal. Chem. 2004; 76: 3660
    • 5f Jon SY, Kim J, Kim M, Park SH, Jeon WS, Heo J, Kim K. Angew. Chem. Int. Ed. 2001; 40: 2116
    • 5g Campayo L, Pardo M, Cotillas A, Jaúregui O, Yunta MJ, Cano C, Gomez-Contreras F, Navarro P, Sanz AM. Tetrahedron 2004; 60: 979
  • 6 Pazik A, Skwierawska A. Sens. Actuators, B 2014; 196: 370
    • 7a Chin J, Walsdorff C, Stranix B, Oh J, Chung HJ, Park S-M, Kim K. Angew. Chem. Int. Ed. 1999; 38: 2756
    • 7b Chin J, Oh J, Jon SY, Park SH, Walsdorff C, Stranix B, Ghoussoub A, Lee SJ, Chung HJ, Park S-M, Kim K. J. Am. Chem. Soc. 2002; 124: 5374
    • 7c Koch N, Seichter W, Mazik M. CrystEngComm 2017; 19: 3817
    • 7d Schulze MM, Koch N, Seichter W, Mazik M. Eur. J. Org. Chem. 2018; 2018: 4317
    • 7e Jonah TM, Mathivathanan L, Morozov AN, Mebel AM, Raptis RG, Kavallieratos K. New J. Chem. 2017; 41: 14835
    • 7f Rueda-Zubiaurre A, Herrero-García N, del Rosario Torres M, Fernández I, Osío Barcina J. Chem. Eur. J. 2012; 18: 16884
    • 7g Ahn KH, Kim S-G, Jung J, Kim K-H, Kim J, Chin J, Kim K. Chem. Lett. 2000; 29: 170
    • 7h Kim H-S, Kim D-H, Kim KS, Choi J-H, Choi H-J, Kim S-H, Shim JH, Cha GS, Nam H. Talanta 2007; 71: 1986
    • 7i Kim H-S, Kim D-H, Kim KS, Choi H-J, Shim JH, Jeong IS, Cha GS, Nam H. J. Inclusion Phenom. Macrocyclic Chem. 2003; 46: 201
    • 7j Oh KS, Lee C-W, Choi HS, Lee SJ, Kim KS. Org. Lett. 2000; 2: 2679
    • 8a Koch N, Seichter W, Mazik M. Tetrahedron 2015; 71: 8965
    • 8b Arunachalam M, Ahamed BN, Ghosh P. Org. Lett. 2010; 12: 2742
  • 9 Fuhrmann F, Meier E, Seichter W, Mazik M. Acta Cryst. 2022; E78 DOI: 10.1107/S2056989022006867.
  • 10 Hynes MJ. J. Chem. Soc., Dalton Trans. 1993; 311
  • 11 Hübler C. Chem. – Methods 2022; e202200006 preprint DOI: 10.1002/cmtd.202200006.
  • 14 Schulze M, Schwarzer A, Mazik M. CrystEngComm 2017; 19: 4003
    • 15a Nishio M. Phys. Chem. Chem. Phys. 2011; 13: 13873
    • 15b Nishio M, Umezawa Y, Honda K, Tsuboyama S, Suezawa H. CrystEngComm 2009; 11: 1757
    • 15c Nishio M, Umezawa Y, Suezawa H, Tsuboyama S. The Importance of Pi-Interactions in Crystal Engineering: Frontiers in Crystal Engineering. Tiekink ERT, Zukerman-Schpector J. Hoboken: Wiley; 2012: 1
  • 16 Desiraju GR, Steiner T. The Weak Hydrogen Bond in Structural Chemistry and Biology. Oxford University Press; Oxford: 1999
  • 17 Spek AL. Acta Cryst. 2015; C71: 9
  • 18 Spek AL. Acta Cryst. 2009; D65: 148
  • 19 Grepioni F, Cojazzi G, Draper SM, Scully N, Braga D. Organometallics 1998; 17: 296
    • 20a Dance I. Encyclopedia of Supramolecular Chemistry. Atwood JL, Steed JM. New York: Dekker; 2004: 1076
    • 20b James SL. Encyclopedia of Supramolecular Chemistry. Atwood JL, Steed JM. New York: Dekker; 2004: 1093
    • 20c Salonen LM, Ellermann M, Diederich F. Angew. Chem. Int. Ed. 2011; 50: 4808
    • Angew. Chem. 2011; 123: 4908
    • 21a Köhler L, Seichter W, Mazik M. Eur. J. Org. Chem. 2020; 2020: 7023
    • 21b Köhler L, Hübler C, Seichter W, Mazik M. RSC Adv. 2021; 11: 22221
  • 22 Koch N, Mazik M. Synthesis 2013; 45: 3341
  • 23 Andree SNL, Sinha AS, Aakeröy CB. Molecules 2018; 23: 163
  • 24 Hartshorn CM, Steel PJ. Aust. J. Chem. 1995; 48: 1587
  • 25 Morin TJ, Wanniarachchi S, Gwengo C, Makura V, Tatlock HM, Lindeman SV, Bennett B, Long GJ, Grandjean F, Gardinier JR. Dalton Trans. 2011; 40: 8024
  • 26 Hillier AC, Zhang XW, Maunder GH, Liu SY, Eberspacher TA, Metz MV, McDonald R, Domingos A, Marques N, Day VW, Sella A, Takats J. Inorg. Chem. 2001; 40: 5106
  • 27 Ardizzoia GA, Brenna S, Durini S, Therrien B, Trentin I. Dalton Trans. 2013; 42: 12265
  • 28 Stoe & Cie. X-AREA and X-RED. Darmstadt, Germany: STOE & Cie GmbH; 2009
  • 29 Sheldrick GM. Acta Cryst. 2015; A71: 3
  • 30 Sheldrick GM. Acta Cryst. 2015; C71: 3

Zoom Image
Figure 1 Structure of the natural ionophore nonactin (a) and examples of tripodal benzene derivatives bearing pyrazolyl groups (b).
Zoom Image
Figure 2 Schematic representations of noncovalent interactions in the crystal structures of two exemplary complexes of hexapodal and tripodal benzene derivatives with NH4PF6: complexes of hexakis[(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)methyl]benzene (left)[8a] and of 1,3,5-tris[(4-methyl-1H-indazol-1-yl)methyl]-2,4,6-triethylbenzene (right).[9]
Zoom Image
Figure 3 Structures of the new 1,3,5-trisubstituted 2,4,6-triethylbenzene or 2,4,6-trimethylbenzene derivatives bearing 4-alkyl-3,5-dimethylpyrazolyl groups.
Zoom Image
Scheme 1 Reaction conditions for the synthesis of compounds 16: NaH, CH3CN, N2 atmosphere (63% of 1, 65% of 2, 72% of 3, 76% of 4, 87% of 5, 63% of 6). Reaction conditions for the preparation of 9 and 10: 3-methylpentan-2,4-dione or 3-ethylpentan-2,4-dione, hydrazine monohydrate, CH3OH, 0 °C and then reflux (90% of 9, 78% of 10).
Zoom Image
Figure 4 Partial 1H NMR spectra (500 MHz, CD3CN/CDCl3 2 : 1, v/v, 298 K) of compound 3 after the addition of (a) 0.00 – 2.05 equiv of NH4PF6 ([3] = 2.53 mM) and (b) 0.00 – 20.09 equiv of KPF6 ([3] = 2.50 mM). Shown are the chemical shifts of the CH3 A (marked by diamonds), CH3 C (marked by triangles), CH3 D and CH3 E signals of 3, for labeling, see (c).
Zoom Image
Figure 5 Partial 1H NMR spectra (500 MHz, CD3CN, 298 K) of compound 1 after the addition of (a) 0.00 – 2.02 equiv of NH4PF6 ([1] = 2.51 mM). Shown are the chemical shifts of the CH3 A (marked by diamonds), CH3 D,F,G, CH2 B (marked by triangles) and CH2 C signals of 1, for labeling, see (b).
Zoom Image
Figure 6 ITC thermogram (left) and titration curve-fitting (right) for the titration of 1 with NH4PF6 in dry CH3CN/CHCl3 2 : 1 (v/v) (the heat of dilution has been subtracted). Titration mode: addition of NH4PF6 (c syringe = 5.9 mM) into 1 (c cell = 0.5 mM) at 298 K in 46 steps, calorimeter: MicroCal VP-ITC.
Zoom Image
Figure 7 Schematic illustration of how the binding efficiency of the investigated compounds is affected by the substituent at 4-position of the pyrazole ring (considered is the binding strength to ammonium hexafluorophosphate). The higher affinity of the triethylbenzene derivatives in comparison to their trimethylbenzene-based analogues is also schematically illustrated in this figure.
Zoom Image
Figure 8 Energy-minimized structure of the 1 : 1 complex 2•NH4PF6 (two different views; the ammonium ion is located in the cavity of compound 2). MacroModel V.11.0, OPLS_2001 force field, MCMM, 50 000 steps; color code: H, white; C, grey; N, blue.
Zoom Image
Figure 9 Structures of compounds 1 – 4 and the composition of the molecular crystals of the complexes 1a4a.
Zoom Image
Figure 10 Perspective views (ORTEP diagrams) of 1 (a) and the ammonium complex in the crystal structure 1a (b) including atom numbering and ring specification. The displacement ellipsoids are drawn at the 40% probability level. Dashed lines represent hydrogen bond interactions. In complex 1a, only the major disorder component of the PF6 ion is shown for clarity.
Zoom Image
Figure 11 Ball-and-stick representations (side views) of 1 (a) and complex 1a (b). Dashed lines represent hydrogen bond interactions.
Zoom Image
Figure 12 Packing diagram of 1. Dashed lines represent hydrogen bond interactions.
Zoom Image
Figure 13 Packing diagram of 1a viewed down the crystallographic c-axis. Dashed lines represent hydrogen bond interactions. Nitrogen atoms are displayed as blue, oxygens as red, fluorine as green and phosphorous atoms as violet circles.
Zoom Image
Figure 14 (a) Perspective view (ORTEP diagrams) of the molecular structure 2a with atom labeling and specification of the aromatic rings. The displacement ellipsoids are drawn at the 40% probability level. (b) Ball-and-stick representations (side views) of the complexes in the crystal structure of 2a. Dashed lines represent hydrogen bond interactions.
Zoom Image
Figure 15 Packing diagram of 2a viewed down the crystallographic a-axis. Dashed lines represent hydrogen bond interactions.
Zoom Image
Figure 16 Perspective view (ORTEP plot) of the molecular structure of 3 including atom numbering and ring specification (A – D). The displacement ellipsoids are drawn at the 40% probability level.
Zoom Image
Figure 17 (a) Excerpt of the packing structure of 3. (b) Structure of the molecular dimer including the labelling of coordinating atoms. Dashed lines represent hydrogen bond interactions and dashed double lines C – H⋯π contacts.
Zoom Image
Figure 18 (a) Perspective view (ORTEP plot) of the molecular structure of complex 3a including atom numbering and ring specification (A – D). The displacement ellipsoids are drawn at the 40% probability level. (b) Ball-and-stick representation (side view) of complex 3a. Dashed lines represent hydrogen bond interactions.
Zoom Image
Figure 19 Packing diagram of 3a viewed down the crystallographic c-axis. Dashed lines represent hydrogen bond interactions.
Zoom Image
Figure 20 Perspective view (ORTEP plot) of the molecular structure of 4a including atom numbering and ring specification (A – D). The displacement ellipsoids are drawn at the 30% probability level. For the sake of clarity, only one position of the disordered ethanol molecules is shown.
Zoom Image
Figure 21 Packing diagram of 4a. Dashed lines represent hydrogen bond interactions.